Controlled deflection of cold atomic clouds and of Bose-Einstein condensates

We present a detailed, realistic proposal and analysis of the implementation of a cold atom deflector using time-dependent far off-resonance optical guides. An analytical model and numerical simulations are used to illustrate its characteristics when applied to both non-degenerate atomic ensembles and to Bose-Einstein condensates. Using for all relevant parameters values that are achieved with present technology, we show that it is possible to deflect almost entirely an ensemble of $^{87}$Rb atoms falling in the gravity field. We discuss the limits of this proposal, and illustrate its robustness against non-adiabatic transitions

Lexiculture et dictionnaires: decalages culturels

L'échange d'informations les plus récentes dans le domaine de la théorie et de la pratique la lexicographie et de la communication, ainsi que dans le domaine de la relation de la langue, de la culture et de la sociét

Off-axis retrieval of orbital angular momentum of light stored in cold atoms

We report on the storage of orbital angu- lar momentum (OAM) of light of a Laguerre-Gaussian mode in an ensemble of cold cesium atoms and its re- trieval along an axis different from the incident light beam. We employed a time-delayed four-wave mixing configuration to demonstrate that at small angle (2o), after storage, the retrieved beam carries the same OAM as the one encoded in the input beam. A calculation based on mode decomposition of the retrieved beam over the Laguerre-Gaussian basis is in agreement with the experimental observations done at small angle values. However, the calculation shows that the OAM retrieving would get lost at larger angles, reducing the fidelity of such storing-retrieving process. In addition, we have also observed that by applying an external magnetic field to the atomic ensemble the retrieved OAM presents Larmor oscillations, demonstrating the possibility of its manipulation and off-axis retrieval.Comment: 9 pages, 4 figure

Negative experimental evidence for magneto-orbital dichroism - supplemental information

A light beam can carry both spin angular momentum (SAM) and orbital angular momentum (OAM). SAM is commonly evidenced by circular dichroism (CD) experiments {\em i. e.} differential absorption of left and right-handed circularly polarized light. Recent experiments, supported by theoretical work, indicate that the corresponding effect with OAM instead of SAM is not observed in chiral matter. Isotropic materials can show CD when subjected to a magnetic field (MCD). In Ref. ~\onlinecite{Mathevet2012} we report a set of experiments, under well defined conditions, searching for magnetic orbital dichroism (MOD), differential absorption of light as a function of the sign of its OAM. We experimentally demonstrate that this effect, if any, is smaller than a few $10^{-4}$ of MCD for the Nd:YAG $^4I_{9/2}\rightarrow^4F_{5/2}$ transition. This transition is essentially of electric dipole nature. We give an intuitive argument suggesting that the lowest order of light matter interaction leading to MOD is the electric quadrupole term. We give here more experimental details and extra measurements.Comment: 6 pages, 7 figures. Supplemental material for a publication in Optics Expres

Bose-Einstein condensation in dark power-law laser traps

We investigate theoretically an original route to achieve Bose-Einstein condensation using dark power-law laser traps. We propose to create such traps with two crossing blue-detuned Laguerre-Gaussian optical beams. Controlling their azimuthal order $\ell$ allows for the exploration of a multitude of power-law trapping situations in one, two and three dimensions, ranging from the usual harmonic trap to an almost square-well potential, in which a quasi-homogeneous Bose gas can be formed. The usual cigar-shaped and disk-shaped Bose-Einstein condensates obtained in a 1D or 2D harmonic trap take the generic form of a "finger" or of a "hockey puck" in such Laguerre-Gaussian traps. In addition, for a fixed atom number, higher transition temperatures are obtained in such configurations when compared with a harmonic trap of same volume. This effect, which results in a substantial acceleration of the condensation dynamics, requires a better but still reasonable focusing of the Laguerre-Gaussian beams

Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy

Multiple system atrophy (MSA) is a sporadic orphan neurodegenerative disorder. No treatment is currently available to slow down the aggressive neurodegenerative process, and patients die within a few years after disease onset. The cytopathological hallmark of MSA is the accumulation of alpha-synuclein (α-syn) aggregates in affected oligodendrocytes. Several studies point to α-syn oligomerization and aggregation as a mediator of neurotoxicity in synucleinopathies including MSA. C-terminal truncation by the inflammatory protease caspase-1 has recently been implicated in the mechanisms that promote aggregation of α-syn in vitro and in neuronal cell models of α-syn toxicity. We present here an in vivo proof of concept of the ability of the caspase-1 inhibitor prodrug VX-765 to mitigate α-syn pathology and to mediate neuroprotection in proteolipid protein α-syn (PLP-SYN) mice, a transgenic mouse model of MSA. PLP-SYN and age-matched wild-type mice were treated for a period of 11 wk with VX-765 or placebo. VX-765 prevented motor deficits in PLP-SYN mice compared with placebo controls. More importantly, VX-765 was able to limit the progressive toxicity of α-syn aggregation by reducing its load in the striatum of PLP-SYN mice. Not only did VX-765 reduce truncated α-syn, but it also decreased its monomeric and oligomeric forms. Finally, VX-765 showed neuroprotective effects by preserving tyrosine hydroxylase-positive neurons in the substantia nigra of PLP-SYN mice. In conclusion, our results suggest that VX-765, a drug that was well tolerated in a 6 wk-long phase II trial in patients with epilepsy, is a promising candidate to achieve disease modification in synucleinopathies by limiting α-syn accumulation

Neolithic genomic data from southern France showcase intensified interactions with hunter-gatherer communities

SummaryArchaeological research shows that the dispersal of the Neolithic took a more complex turn when reaching western Europe, painting a contrasted picture of interactions between autochthonous hunter-gatherers (HGs) and incoming farmers. In order to clarify the mode, the intensity, and the regional variability of biological exchanges implied in these processes, we report new palaeogenomic data from Occitanie, a key region in Southern France. Genomic data from 28 individuals originating from six sites spanning from c. 5,500 to c. 2,500 BCE allow us to characterize regional patterns of ancestries throughout the Neolithic period. Results highlight major differences between the Mediterranean and Continental Neolithic expansion routes regarding both migration and interaction processes. High proportions of HG ancestry in both Early and Late Neolithic groups in Southern France support multiple pulses of inter-group gene flow throughout time and space and confirm the need for regional studies to address the complexity of the processes involved

MTN-001: Randomized Pharmacokinetic Cross-Over Study Comparing Tenofovir Vaginal Gel and Oral Tablets in Vaginal Tissue and Other Compartments

Background: Oral and vaginal preparations of tenofovir as pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection have demonstrated variable efficacy in men and women prompting assessment of variation in drug concentration as an explanation. Knowledge of tenofovir concentration and its active form, tenofovir diphosphate, at the putative vaginal and rectal site of action and its relationship to concentrations at multiple other anatomic locations may provide key information for both interpreting PrEP study outcomes and planning future PrEP drug development. Objective: MTN-001 was designed to directly compare oral to vaginal steady-state tenofovir pharmacokinetics in blood, vaginal tissue, and vaginal and rectal fluid in a paired cross-over design. Methods and Findings: We enrolled 144 HIV-uninfected women at 4 US and 3 African clinical research sites in an open label, 3-period crossover study of three different daily tenofovir regimens, each for 6 weeks (oral 300 mg tenofovir disoproxil fumarate, vaginal 1% tenofovir gel [40 mg], or both). Serum concentrations after vaginal dosing were 56-fold lower than after oral dosing (p<0.001). Vaginal tissue tenofovir diphosphate was quantifiable in ≥90% of women with vaginal dosing and only 19% of women with oral dosing. Vaginal tissue tenofovir diphosphate was ≥130-fold higher with vaginal compared to oral dosing (p<0.001). Rectal fluid tenofovir concentrations in vaginal dosing periods were higher than concentrations measured in the oral only dosing period (p<0.03). Conclusions: Compared to oral dosing, vaginal dosing achieved much lower serum concentrations and much higher vaginal tissue concentrations. Even allowing for 100-fold concentration differences due to poor adherence or less frequent prescribed dosing, vaginal dosing of tenofovir should provide higher active site concentrations and theoretically greater PrEP efficacy than oral dosing; randomized topical dosing PrEP trials to the contrary indicates that factors beyond tenofovir's antiviral effect substantially influence PrEP efficacy. Trial Registration: ClinicalTrials.gov NCT00592124